KeyaMedical
  • Home
  • Products
    • DeepVessel FFR
    • CuraRad-ICH
  • Solutions
    • Diagnostic Solutions
    • Treatment Solutions
  • About Us
  • Resources
    • News
    • Publications
    • Glossary
  • Contact Us
    • DeepVessel FFR Demo
    • Solutions Inquiry
  • Careers
Select Page
DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China

DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China

by KeyaMedical | Apr 13, 2021 | All News, Press

Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.

Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography

Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography

by KeyaMedical | Apr 2, 2021 | All News

A new study conducted by researchers at the First Affiliated Hospital of Jinan University demonstrates that deep learning-based CT-FFR (DL-CTFFR) can reduce the need for invasive coronary angiography (ICA) and improve outcomes in patients with stable coronary artery disease (CAD).

Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations

Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations

by KeyaMedical | Mar 20, 2021 | All News, Blog

Evidence is building in support of a coronary CTA-first strategy for evaluating patients with stable coronary artery disease. Learn more about the current evidence, guidelines, and recommendations.

Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List

Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List

by KeyaMedical | Feb 25, 2021 | All News, Press

Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.

The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes

The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes

by KeyaMedical | Feb 10, 2021 | All News, Blog

Researchers at Fuwai Hospital conducted a retrospective study to evaluate the performance of Keya Medical’s deep learning-based CT-FFR product in detecting hemodynamic changes in stenosis.

Putting the Spotlight on Women’s Hearts: Cardiovascular Disease in Women

Putting the Spotlight on Women’s Hearts: Cardiovascular Disease in Women

by KeyaMedical | Feb 8, 2021 | All News

Cardiovascular disease (CVD) remains the leading cause of death for women in the U.S. In honor of American Heart Month, we are highlighting the differences in women’s risk factors and primary prevention to help manage CVD in women.

« Older Entries

Categories:

Recent Posts

  • DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
  • Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography
  • Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations
  • Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
  • The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes

Recent Comments

    Copyright Keya Medical © 2021